Home
Home

Europe

Pfizer says EU starts review of 2 cancer drugs

Pfizer says EU starts review of 2 cancer drugs
Yahoo/AP

Zeltia Says Yondelis-Related Drug May Suffer Supply Constraints

Zeltia Says Yondelis-Related Drug May Suffer Supply Constraints
Bloomberg

Botox gets EU green light as bladder treatment

Botox gets EU green light as bladder treatment
Fierce Pharma
Submitted by moderatorj on Tue, 08/02/2011 - 17:39

Delcath to Base European Operations in Galway, Ireland

Delcath to Base European Operations in Galway, Ireland
PR Newswire

Europe reviews rules on pharma-patient interaction

Europe reviews rules on pharma-patient interaction
Fierce Pharma

Biogen wins conditional EU approval for MS drug

Biogen wins conditional EU approval for MS drug
Bizjournals.com

EMA Says Benefits From Pfizer’s Champix Outweigh Heart Risks

EMA Says Benefits From Pfizer’s Champix Outweigh Heart Risks
Bloomberg

Amgen's Xgeva Wins EU Approval

Amgen's Xgeva Wins EU Approval
Yahoo/Zacks.com
Submitted by admin on Mon, 07/18/2011 - 17:41

Endologix ends Europe distribution agreement

Endologix ends Europe distribution agreement
Yahoo/Zacks.com
Submitted by moderatorj on Fri, 07/15/2011 - 15:04

St. Jude Medical's Novel Heart Disease Diagnostic Tool Cleared in Europe

St. Jude Medical's Novel Heart Disease Diagnostic Tool Cleared in Europe
The Motley Fool